This announcement is a separate document:
領航醫藥生物科技：延遲刊發截至二零二二年三月三十一日止年度之經審核年度業績及截至二零二二年三月三十一日止年度之未經審核年度業績公告
INNOVATIVE PHAR: DELAY IN PUBLICATION OF AUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 MARCH 2022 AND ANNOUNCEMENT OF UNAUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 MARCH 2022
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.